Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Aromando Insider Profile
4 Followers
Andrew Aromando, COO at Ambrx Biopharma, holds 109.26K shares in Ambrx Biopharma (Ticker: AMAM).
Andrew Aromando Ambrx Biopharma (AMAM)COO
Ambrx Biopharma (AMAM)
COO
Not Ranked
Andrew Aromando has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Andrew Aromando does not currently own shares as a corporate insider.
A breakdown of Andrew Aromando's holdings
Insider Roles
Andrew Aromando does not currently hold a role as a corporate insider.
Roles that Andrew Aromando holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Andrew Aromando
Andrew Aromando's Trading History
List of latest transactions for each holding click on a transaction to see Andrew Aromando's performance on stock
You May Also Like
Andrew Aromando insider profile FAQ
What is the percentage of profitable transactions made by Andrew Aromando?
The percentage of profitable transactions made by Andrew Aromando is ―.
What is the average return per transaction made by Andrew Aromando?
The average return per transaction made by Andrew Aromando is ―.
What stocks does Andrew Aromando hold?
Andrew Aromando holds: AMAM stocks.
What was Andrew Aromando’s latest transaction?
Andrew Aromando latest transaction was an Uninformative Buy of ―.
What was Andrew Aromando's most profitable transaction?
Andrew Aromando’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Andrew Aromando's role in Ambrx Biopharma?
Andrew Aromando's role in Ambrx Biopharma is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.